Solutions
Drug Development
Pulmonary Interventions
Therapeutic Areas
COPD
Bronchiectasis Disease
Severe Asthma
Cystic Fibrosis
Technology
Evidence & Expertise
Publications
Research Projects
Blog
Advisory Board
Company
About Us
Events
Quality & Compliance
News
Career
Contact
Solutions
Drug Development
Pulmonary Interventions
Therapeutic Areas
COPD
Bronchiectasis Disease
Severe Asthma
Cystic Fibrosis
Technology
Evidence & Expertise
Publications
Research Projects
Blog
Advisory Board
Company
About Us
Events
Quality & Compliance
News
Career
Contact
Let's talk
Evidence & Expertise Insights
Blogs
Optimizing Imaging Outcomes: Why Lung Volume Control Can Make or Break the Success of a Respiratory Clinical Trial
Read more
Phenotyping vascular lung disease patients: new ways with imaging-based markers
Read more
Beyond the Algorithm – Driving Clinical Impact Through Compliance
Read more
Redefining Bronchiectasis Trials Through AI-Powered Image Analysis
Read more
Comprehensive assessment of mucus impaction with Artificial Intelligence
Read more
AI in phenotyping of pulmonary blood vessels: Redefining diagnosis and treatment of pulmonary vascular diseases
Read more
More blogs
Webinars
26/03/2026
Role of AI imaging in respiratory trials
Harm Tiddens
Watch now
Register now
more webinars
Technology explainers
From invisible details to powerful insights – LungQ®
Watch now
From invisible details to powerful insights – LungQ® Mucus Plug Analysis
Watch now
From invisible details to powerful insights – LungQ®
Watch now
LungQ™ AVX – deep characterization of the pulmonary vasculature
Watch now
More videos
Publications highlights
more publication highlights
Talks & perspectives
Talk & Perspective1
Talk & Perspective1 text
Watch now
Talk & Perspective 2
Talk & Perspective 2 text
Watch now
More Talks & Perspectives